Diagnostic accuracy of 64-slice multi-detector CT coronary angiography in the evaluation of coronary artery disease.
- Author:
Sung Min KO
1
Author Information
1. Department of Radiology, Konkuk University Hospital, Konkuk University College of Medicine, Seoul, Korea.
- Publication Type:Editorial
- Keywords:
Coronary artery disease;
Coronary CT angiography;
Conventional angiography;
Multi-detector computed tomography
- MeSH:
Angiography;
Constriction, Pathologic;
Coronary Angiography;
Coronary Artery Disease;
Coronary Stenosis;
Coronary Vessels;
Family Characteristics;
Glycosaminoglycans;
Humans
- From:Korean Journal of Medicine
2008;75(1):39-41
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Conventional coronary angiography (CCA) has been the gold standard for the detection of significant coronary artery disease (CAD). However, CCA is invasive and 2/3 of all CCA have been performed for the diagnosis of significant stenosis without intervention. Recently, the use of multi-detector CT (MDCT) coronary angiography has been rapidly evolving as a promising non-invasive method for the assessment of patients with CAD. With the advent of 64-slice MDCT scanner, both temporal and spatial resolutions of coronary CT angiography have further improved for the non-invasive detection of coronary stenoses. The diagnostic performance for the assessment of CAD has significantly improved, and the nonassessable proportion of segments significantly decreased with the newer generations of MDCT scanners. Namgung et al. reported that high diagnostic accuracy for 64-slice MDCT in the detection of significant stenosis (> or =50% lumen diameter narrowing) on per segment (96% sensitivity and 97% specificity), per vessel (96% sensitivity and 97% specificity), and per patient analyses (100% sensitivity and 94% specificity). The negative predictive value for classification of segments, vessels, and patients with or without CAD was very high (99-100%). These findings indicate that 64-slice MDCT coronary angiography can be reliable as a gatekeeper of CCA in selected groups of patients.
